C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom

Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
10/2006
10/26/2006	US20060241101 Novel benzimidazole derivatives and pharmaceutical compositions comprising these compounds
10/26/2006	US20060240048 Pyridine derivatives as cb2 receptor modulators
10/26/2006	DE102005017116A1 Hemmstoffe für Inhibitoren von Apoptose Proteinen (IAP) Inhibitors of inhibitors of apoptosis proteins (IAP)
10/26/2006	CA2643677A1 Compositions of novel opioid compounds and method of use thereof
10/26/2006	CA2610446A1 Nitrogen-containing heterocyclic compound
10/26/2006	CA2606288A1 Subtituted heteroaryl cb1 antagonists
10/26/2006	CA2605276A1 Cyano anthranilamide insecticides
10/26/2006	CA2605059A1 Oxindole compounds and their uses as therapeutic agents
10/26/2006	CA2604956A1 Protective agent for retinal neuronal cell comprising indazole derivative as active ingredient
10/26/2006	CA2604942A1 2-amino-quinaz0lin-5-ones
10/26/2006	CA2604920A1 Novel compounds useful for bradykinin b1 receptor antagonism
10/26/2006	CA2604581A1 Combinations, methods and compositions for treating cancer
10/26/2006	CA2603835A1 Vla-4 antagonists
10/26/2006	CA2601979A1 2,3 substituted pyrazine sulfonamides
10/26/2006	CA2600774A1 Pharmaceutically active diazepanes
10/25/2006	EP1714961A1 Indazole compound and pharmaceutical use thereof
10/25/2006	EP1714654A1 Drug for inhibiting vascular intimal hyperplasia
10/25/2006	EP1713823A2 Hcv ns-3 serine protease inhibitors
10/25/2006	EP1713822A2 Hcv ns-3 serine protease inhibitors
10/25/2006	EP1713807A1 Vanilloid receptor ligands and their use in treatments
10/25/2006	EP1713803A1 7-phenylamino-4-quinolone-3-carboxylic acid derivatives, methods for production and use thereof as medicaments
10/25/2006	EP1713797A1 1-ISOPROPYL-2-OXO-1,2-DIHYDROPYRIDINE-3-CARBOXAMIDE DERIVATIVES HAVING 5-HT sb 4 /sb RECEPTOR AGONISTIC ACTIVITY
10/25/2006	EP1713793A2 Pyrimidinone compounds useful as kinase inhibitors
10/25/2006	EP1713792A2 SALT FORMS OF 4-(4-METHYLPIPERAZIN-1-YLMETHYL)-n- 4-METHYL-3 -(4-PYRIDIN-3-YL)PYRIMIDIN-2-YLAMINO)PHENYL -BENZAMIDE
10/25/2006	EP1713791A1 5-fluoro-, chloro- and cyano-pyridin-2-yl-tetrazoles as ligands of the metabotropic glutamate receptor-5
10/25/2006	EP1713790A2 Method of preparation of benzofuran-2-carboxylic acid (s)-3-methyl-1- ((4s, 7r)-7methyl-3-oxo-1-(pyridine-2-sulfonyl)-az epan-4-ylcarbamoyl-butyl)-amide
10/25/2006	EP1713782A1 Pth agonists
10/25/2006	EP1713781A1 Quinazoline derivatives
10/25/2006	EP1713778A1 Benzazepine derivatives as histamine h3 antagonists
10/25/2006	EP1713774A1 New pyridin-2-one compounds useful as inhibitors of thrombin
10/25/2006	EP1713772A1 Novel piperidines as chemokine modulators (ccr)
10/25/2006	EP1713484A2 Compounds and methods of use
10/25/2006	EP1590346B1 4- {'3-(sulfonylamino) phenyl] '1-(cyclymethyl) piperidin-4-ylidene] methyl} benazmide derivatives as delta opioid receptor ligands for the treatment of pain, anxiety and functional gastrointestinal disorder
10/25/2006	EP1554272B1 Benzimidazoles and benzothiazoles as inhibitors of map kinase
10/25/2006	EP1458718B1 Quinolinones as prostaglandin receptor ligands
10/25/2006	EP1401416B1 Use of c-kit inhibitors for treating inflammatory bowel diseases (ibd)
10/25/2006	EP1265606B1 Cell adhesion inhibitors
10/25/2006	EP1235805B1 Immunoassay for neonicotinyl insecticides
10/25/2006	EP1157006B1 Phenyl- and pyridinyl derivatives as neurokinin 1 antagonists
10/25/2006	CN1852910A Coordination metal compound, material for organic electroluminescence device, material for luminescent coating formation and organic electroluminescence device
10/25/2006	CN1852905A N-substituted benzimidazolyl c-kit inhibitors
10/25/2006	CN1852900A 2,4-di (phenylamino) pyrimidines useful in the treatment of proliferative disorders
10/25/2006	CN1852897A Gabanergic modulators
10/25/2006	CN1852896A Quinoline and quinazoline derivatives having affinity for 5HT1-type receptors
10/25/2006	CN1852895A 4-pyridinylmethyl sulfonamide derivatives as fungicidal plant protection agents
10/25/2006	CN1852714A Quinazoline analogs as receptor tyrosine kinase inhibitors
10/25/2006	CN1852712A Dual NK1/NK3 antagonists for treating schizophrenia
10/25/2006	CN1852710A Pyrazolines as PAR-1 antagonists for treatment of cardiovascular diseases
10/25/2006	CN1850823A Quinolone compound containing oximino, and its preparing method and use
10/25/2006	CN1281605C Heterocyclylindazole and -azaindazole compounds as 5-hydroxytryptamine-6 ligands
10/25/2006	CN1281604C Substituted pyrazole compounds
10/25/2006	CN1281603C Aminopyrrole compounds as antiinflammatory agents
10/25/2006	CN1281602C Novel carboxylate herbicides
10/25/2006	CN1281601C Bipyridyl derivatives as a highly selective cyclooxygenase-2 inhibitor
10/25/2006	CN1281591C 4-aminopicolinates and their use as herbicides
10/25/2006	CN1281590C Hexavalent amino amidate derivative with function of inhibiting blood vessel growth activity
10/25/2006	CN1281588C Novel intermediate for preparation of pyrazolopyrimidinones
10/25/2006	CN1281585C Cyclic diamine compounds having fused-ring groups
10/24/2006	US7126012 Has affinity for melatonin receptors and/or selectivity for melatoninergic receptors; antiinflammatory and anticarcinogic agents
10/24/2006	US7126010 Benzylcycloalkyl amines as modulators of chemokine receptor activity
10/24/2006	US7126009 Palladium catalyzed indolization of 2-bromo or chloroanilines
10/24/2006	US7126007 Reproducible; avoids use of 3-pyrrolidinol as a starting material
10/24/2006	US7126003 Enzyme hydrolysis of ester
10/24/2006	US7126002 Pyridine-1-oxide derivative, and process for its transformation into pharmaceutically effective compounds
10/24/2006	US7125997 Differential tumor cytotoxicity compounds and compositions
10/24/2006	US7125995 Substituted amidoalkyl uracils and their use as inhibitors of the poly(adp-ribose) synthetase (PARS)
10/24/2006	US7125990 For treatment of depression, anxiety, affective disorders, feeding disorders, post-traumatic stress disorder, headache, drug addiction, inflammatory disorders, drug or alcohol withdrawal symptoms
10/24/2006	US7125905 Pyrrole substituted 2-indolinone protein kinase inhibitors
10/24/2006	US7125898 Kinase inhibitors to mediate disease and as antiinflammatory agents
10/24/2006	US7125895 Arylalkylamine compounds as chemokine receptor antagonists for therapy and prevention of diseases such as arthritis or rheumatic diseases
10/24/2006	US7125892 Aryl aniline β2 adrenergic receptor agonists
10/24/2006	US7125891 Such as (1-((2,3-dihydro-2-(4-propyl-1H-imidazol-2-yl)-1H-indol-1 -yl)carbonyl)propyl)-carbamate; for inactivation of cholecystokinins
10/24/2006	US7125887 Pyrrolidine modulators of CCR5 chemokine receptor activity
10/24/2006	US7125883 alpha v beta 3 integrin receptor modulators; treating variety of diseases including cardiovascular disorders, retinopathy, strokes, cancer, osteoporosis, tumor metastasis, high blood pressure, psoriasis, antiviral, antimycotic, antiparasitic or antibacterial therapy; 1,2-dihydropyrimidin-2-one moiety
10/24/2006	US7125881 Use of pyrimidine—or triazine—2 carbonitiles for treating diseases associated with cysteine prostease activity and novel pyrimidine-2-carbonitile derivatives
10/24/2006	US7125879 Prevention reproduction of virus
10/24/2006	US7125877 Brain disorders; psychological disorders; central nervous system disorders; antidiabetic agents; hypotensive agents
10/24/2006	US7125866 Therapeutic applications of pro-apoptotic benzodiazepines
10/24/2006	US7125863 Inhibitors of dipeptidyl peptidase IV
10/24/2006	US7125840 Substituted dipeptides as growth hormone secretagogues
10/24/2006	CA2398963C New salt form and polymorphs
10/24/2006	CA2300603C New compounds of the benzylaminodiacetamide family, formulations including them, preparation process and uses
10/24/2006	CA2261848C Cell adhesion inhibitors
10/24/2006	CA2252952C Substituted aminomethylphenylsulphonylureas, their preparation, and their use as herbicides and plant growth regulators
10/24/2006	CA2246678C Substituted 2-aryl-1,2,4-triazine-3,5-di(thi)ones as herbicides
10/24/2006	CA2223094C Phenylpyridazinones
10/24/2006	CA2214752C Herbicidal or fungicidal sulphonylaminocarbonyltriazolinones with halogenated alk(en)oxy substituents
10/24/2006	CA2211411C Sulphonyl amino(thio)carbonyl-1,2,4-triazolin(thi)one derivatives, the production thereof and the use thereof as herbicides
10/19/2006	WO2006110884A2 2, 6-di (hetero) aryl -4-amido-pyrimidines as adenosine receptor antagonists
10/19/2006	WO2006110816A2 1h-benzimidazole-4-carboxamides substituted with a quaternary carbon at the 2-position are potent parp inhibitors
10/19/2006	WO2006110683A1 2-substituted-1h-benzimidazole-4-carboxamides are parp inhibitors
10/19/2006	WO2006109846A1 Triazole derivative and the use thereof
10/19/2006	WO2006109817A1 1,4-substituted piperazine derivative
10/19/2006	WO2006109729A1 Pyridylmethylsulfone derivative
10/19/2006	WO2006109680A1 Use of 3,5-diphenylpyrazole analogue as anti-tumor agent
10/19/2006	WO2006109633A1 Substituted indole compound
10/19/2006	WO2006109085A1 Hydroxybenzamide derivatives and their use as inhibitors of hsp90
10/19/2006	WO2006108800A1 Benzimidazole derivatives and their use for modulating the gabaa receptor complex
10/19/2006	WO2006108791A2 Heterocyclylethylheterocyclylcarboxamide derivatives as fungicides
10/19/2006	WO2006108711A1 Substituted chroman derivatives, method for the production and the use thereof in the form of antiphlogistics

1 ... 481 482 483 484 485 486 487 488 489 490 491 492 493 494 495 496 497 498 499 500 501 ... 1080